Immune Checkpoint Inhibitor‐Associated Primary Adrenal Insufficiency: WHO VigiBase Report Analysis

BACKGROUND: Immune checkpoint inhibitors (ICIs) have transformed cancer therapy but may also trigger autoimmune adverse drug reactions (ADRs) referred to as immune‐related adverse events (irAEs). Although endocrinopathies are among the most common form of irAEs, primary adrenal insufficiency (PAI) i...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncologist
Main Authors: Grouthier, Virginie, Lebrun‐Vignes, Bénédicte, Moey, Melissa, Johnson, Douglas B., Moslehi, Javid J., Salem, Joe‐Elie, Bachelot, Anne
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2020
Teme:
Immuno‐Oncology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7418341/
https://ncbi.nlm.nih.gov/pubmed/32390168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0555
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki